| Metric | Current Period | Prior Year Period | YoY |
|---|---|---|---|
| Revenue / Net Sales | ¥9239.6B | ¥8018.7B | +15.2% |
| Operating Income | ¥3045.5B | ¥2443.2B | +24.7% |
| Ordinary Income | ¥2876.6B | ¥2214.5B | +29.9% |
| Net Income | ¥1972.4B | ¥1582.3B | +24.7% |
| ROE | 4.8% | 3.8% | - |
FY2026 Q1 delivered double-digit revenue and profit growth driven by pricing effects in the global tobacco business and an improved high-value product mix. Revenue expanded robustly to ¥9,239.6B (¥8,018.7B in the prior-year period, +¥1,220.9B, +15.2%), and Operating Income rose to ¥3,045.5B (¥2,443.2B, +¥602.3B, +24.7%), outpacing sales growth. Net Income increased to ¥1,972.4B (¥1,582.3B, +¥390.1B, +24.7%), growing at nearly the same rate as Operating Income, confirming profitability improvement across the P&L. Adjusted Operating Income was ¥3,155.2B (¥2,568.9B, +22.8%), with a reduction in acquisition-related intangible amortization of ¥120.9B and lower financial costs driving a high conversion from operating to net profit. By region, all clusters — Asia, Western Europe, and EMA — posted double-digit operating profit growth, supported by price realizations in key markets and maintained share momentum. Progress toward the full-year forecast is ahead of schedule: Operating Income progress ratio at 33.1% and Net Income attributable to parent at 34.6%, both well above the standard 25%.
[Revenue] Revenue of ¥9,239.6B (+15.2%) was mainly driven by pricing actions in key tobacco markets including Japan, Russia, Turkey, and the US contributing +¥682B, together with resilient volumes (Combustibles total volume +0.9%, RRP volume +44.2%). Own-brand tobacco product sales were ¥8,485B (+16.2%, constant FX +10.1%) with the Tobacco segment accounting for ¥8,855.5B (+15.8%) or 95.8% of company revenue. Processed Food sales were ¥378.3B (+3.7%), supported by price adjustments. FX contributed +¥59B due to major currency strength, with a strong Russian ruble performance adding to constant-FX outperformance. Geographically, the EMA cluster was the largest contributor with sales of ¥4,158.7B (+12.8%); Western Europe ¥2,046.8B (+2.7%); Asia ¥2,279.8B (+12.0%).
[Profitability] Cost of sales was contained at ¥3,790.0B (41.0% of sales), lifting gross margin to 59.0% (prior year 57.7%), a +1.3pt improvement, and gross profit to ¥5,449.6B (+18.2%), outpacing revenue growth. SG&A was ¥2,469.8B (26.7% of sales, prior year 28.0%), reflecting continued efficiency gains and supporting expansion of operating-level profits. From Adjusted Operating Income of ¥3,155.2B (+22.8%, constant FX +20.5%), deductions included acquisition intangible amortization ¥120.9B (prior year ¥174.9B), Canada adjustment (Annual contribution) ¥39.9B, and adjustment items ¥28.7B (restructuring, etc.), resulting in Operating Income of ¥3,045.5B (+24.7%). Operating margin improved by ~+2.5pt to 33.0% (prior year 30.5%), reflecting structural margin improvement led by price/MIX. Financial income was ¥173.5B and financial expenses ¥342.4B, reducing net finance costs to ¥168.9B (prior year ¥228.7B). Equity-method profit contributed ¥21.8B, bringing Ordinary Income to ¥2,876.6B (+29.9%). With an effective tax rate of 31.4% (income taxes ¥904.2B), quarterly Net Income was ¥1,972.4B (+24.7%), confirming a clear revenue-and-profit growth profile.
The core business is Tobacco, with sales of ¥8,855.5B (95.8% of group), Adjusted Operating Income of ¥3,254.1B (103.1% of group on adjusted basis), and an Adjusted Operating Margin of 36.7%, representing a dominant profit contribution. Year-on-year, Tobacco sales +15.8% and operating profit +21.4% (constant FX +19.2%) were sustained, driven by pricing effects +¥682B, volume effect -¥121B, other -¥46B, and FX +¥59B. By region: Asia (sales ¥2,279.8B, Adjusted Operating Income ¥886.9B, margin 38.9%, YoY +26.7%), Western Europe (sales ¥2,046.8B, Adjusted Operating Income ¥963.4B, margin 47.1%, YoY +6.1%), EMA (sales ¥4,158.7B, Adjusted Operating Income ¥1,403.8B, margin 33.8%, YoY +23.9%) — all achieved revenue and profit growth with strong share momentum. RRP (heated tobacco, etc.) saw significant growth led by Ploom: volumes 4.3B units (+44.2%), Ploom share in Japan 15.8% (+1.8pt), Italy 1.4% (+0.7pt), accelerating across markets and expected to be a future growth driver. Processed Food sales ¥378.3B (+3.7%) and Operating Income ¥17.4B (+119.0%) expanded profit, though margin remains low at 4.6%; price adjustments outpaced raw material cost inflation. Other segments posted sales ¥5.8B and Operating loss ¥116.4B (prior year -¥113.9B), reflecting ongoing headquarters cost burdens. Profit margin dispersion across segments is pronounced: high Tobacco margins lift the group average of 33.0%, while Processed Food has substantial room for profitability improvement.
Profitability: ROE 4.8% (prior year 5.7%), Operating Margin 33.0% (prior year 30.5%), Net Income Margin 21.3% (prior year 19.7%) — margin metrics broadly improved. The ROE decline is mainly due to an increase in total assets from working capital expansion; net income growth +24.7% vs. total assets roughly unchanged mid-period (ending ¥8,351.21B vs. prior year-end ¥8,419.2B). Adjusted Operating Margin was 34.2% (Adjusted Operating Income ¥3,155.2B / Revenue ¥9,239.6B), indicating very strong underlying earning power before acquisition-related amortization. Cash quality: Operating Cash Flow / Net Income = 0.20x, low, driven by working capital deterioration (accounts receivable increase +¥681.9B, inventory increase +¥117.3B, trade payables decrease +¥439.6B). Operating Cash Flow was ¥395.9B (prior year -¥65.7B), turning positive, yet still well below Net Income ¥1,972.4B. Free Cash Flow was ¥271.0B (Operating CF ¥395.9B - CapEx ¥240.4B), insufficient to cover dividend payments of ¥2,258.8B, funded by cash reduction and short-term borrowings. Investment efficiency: CapEx / Depreciation = 0.54x (CapEx ¥240.4B / Depreciation ¥444.5B), indicating maintenance-focused investment rather than growth. Total asset turnover is low at 0.111x (Revenue ¥9,239.6B / ending total assets ¥8,351.21B annualized), weighed down by large goodwill and goodwill-related assets. Financial soundness: Equity Ratio 48.9% (Equity ¥4,114.89B / Total Assets ¥8,351.21B), Current Ratio 1.88x (Current Assets ¥3,587.37B / Current Liabilities ¥1,906.66B) — solid. Interest-bearing debt (bonds and borrowings) totaled ¥1,777.63B (short-term ¥224.18B, long-term ¥1,553.45B), Debt/Capital about 30.2%, and Interest Coverage (~Operating Income ¥3,045.5B / Financial Expenses ¥342.4B) about 8.9x — comfortable. However, goodwill at ¥2,954.54B represents 71.8% of equity and 35.4% of total assets, posing structural impairment sensitivity.
Operating Cash Flow: ¥396.0B (0.20x of Net Income) — cash backing of earnings is very weak. Pre-working-capital subtotal was ¥920.1B (Ordinary Income ¥2,876.6B adjusted for depreciation and non-cash items), offset by large cash outflows: accounts receivable increase -¥681.9B, inventories increase -¥117.3B, trade payables decrease -¥439.6B, changes in prepaid tobacco tax +¥272.6B, decrease in accrued tobacco taxes -¥1,014.3B, plus corporate tax payments -¥614.0B and interest payments -¥131.2B, resulting in limited operating cash generation. Prior year Q1 Operating CF was -¥65.7B; this period turned positive but seasonal and tobacco-tax timing distortions heavily influenced the result. Investing CF: -¥124.9B, driven by CapEx -¥240.4B (mainly manufacturing capacity and RRP investments), partially offset by term deposit withdrawals +¥1,472.9B and deposits -¥1,306.8B net +¥166.1B. Intangible asset additions -¥30.7B and acquisition of investments -¥5.5B included; investment activity was restrained. Financing CF: -¥1,598.2B, with dividend payments -¥2,258.8B (parent company -¥2,258.8B, non-controlling interests -¥4.1B) the largest outflow. Short-term borrowings/CP increased +¥1,419.1B, bond redemptions -¥675.3B, long-term borrowings repayments -¥1.1B, share buybacks -¥8.4B, lease payments -¥69.6B — dividends were funded during the period by interim borrowing and cash drawdown. FCF was ¥271.0B (Operating CF ¥396.0B - CapEx ¥240.4B), far below dividend payments of ¥2,258.8B. Cash and cash equivalents decreased by ¥1,365.2B from opening ¥8,311.4B to closing ¥6,946.2B, including FX effects -¥11.0B; liquidity declined. Cash generation requires monitoring. The fact Operating CF significantly lags Net Income and dividends materially exceed FCF are near-term warning signals, but given the seasonality of working capital (tobacco tax prepaid/accrued timing distortions), there is substantial room for improvement on a half/full-year basis. Sustained FX and pricing effects and reversal of working capital will be key for cash generation.
Earnings quality is high and centered on recurring profit. Starting from Adjusted Operating Income ¥3,155.2B, exclusion items include acquisition intangible amortization ¥120.9B (prior year ¥174.9B), Canada adjustment ¥39.9B (installment equivalent of litigation settlement), adjustment items (income) ¥0.1B and (expenses) ¥28.8B (mainly restructuring), yielding Operating Income ¥3,045.5B. One-off items are limited to adjustments, confirming structurally high earning power. Non-operating income comprised Financial Income ¥173.5B (1.9% of sales), and Financial Expenses ¥342.4B (3.7% of sales), both small as a percentage of sales. The gap between Ordinary Income (Ordinary Income ¥2,876.6B) and Net Income ¥1,972.4B is explained by the effective tax rate of 31.4% (income taxes ¥904.2B) with no large one-time discrepancies. Comprehensive income was ¥2,328.8B; the ¥356.4B difference from Net Income ¥1,972.4B was mainly FX translation adjustments from overseas operations +¥292.6B, cash flow hedges +¥63.0B, and fair value changes of financial assets through other comprehensive income +¥3.6B, indicating valuation-related earnings volatility. Accrual ratio ((Net Income ¥1,972.4B - Operating CF ¥396.0B) / Total Assets ¥8,351.21B) ≈ 1.9%, low, suggesting earnings quality is fundamentally sound. However, the large gap where Operating CF lags Net Income raises a temporary concern about cash conversion, driven by enormous working capital swings (DSO 279 days, DIO 1,049 days, CCC 682 days). Considering tax payments and seasonality, the weak cash conversion in a single quarter likely reflects transitory factors and recovery is expected on a half/full-year basis.
Full-year guidance remains unchanged: Revenue ¥3,697.0B, Operating Income ¥921.0B (+6.2% YoY), Net Income attributable to parent ¥570.0B. Q1 progress rates: Revenue 25.0% (in line with standard 25%), Operating Income 33.1% (8.1pt above standard 25%), Net Income attributable to parent 34.6% (+9.6pt above). The ahead-of-schedule profit progression is due to early realization of pricing effects, resilient volumes (Combustibles +0.9%, RRP +44.2%), favorable FX +¥59B, reduced acquisition-related intangible amortization (¥174.9B → ¥120.9B), and lower financial expenses (¥401.8B → ¥342.4B). Adjusted Operating Income constant-FX growth of +20.5% far exceeds the company’s mid-to-high single-digit medium-term annual target. From Q2 onwards, if working capital unwinds (accounts receivable collection progress, inventory compression, trade payable restoration), Operating CF should improve and full-year progress could further strengthen. Conversely, FX reversals (e.g., ruble depreciation), regulatory/litigation risks, or Middle East geopolitical deterioration could slow progress; however, management currently expresses confidence in achieving the full-year outlook. Acceleration of RRP top-line growth (driven by Ploom) and continued multi-market share momentum are keys to upside to the full-year forecast.
Full-year dividend forecast for FY2026 is ¥121 per share (prior year ¥121 per share), unchanged. The payout ratio is calculated at 75.2% based on adjusted net income after the Canada settlement of ¥571.0B, and the total return ratio via dividends alone is 75.2% (share buybacks are minimal, so effectively equivalent to payout ratio). Q1 dividend payment of ¥2,258.8B (parent company shareholders) far exceeded Free Cash Flow ¥271.0B, leaving quarterly dividend coverage insufficient. Nevertheless, given the company’s strong earning power (Adjusted Operating Margin 34.2%, Operating Margin 33.0%), low leverage (Debt/Capital ≈ 30%), and potential CF improvement from working capital seasonality, securing dividend funding on a full-year basis is broadly expected. Share buybacks were minimal at ¥8.4B; the shareholder return policy remains dividend-focused. Risks to dividend sustainability include: (i) weak cash conversion indicated by Operating CF / Net Income 0.20x; (ii) persistence of large working capital swings (CCC 682 days) that would maintain liquidity pressure; (iii) major adverse FX moves (e.g., sharp ruble decline) causing profit downside. On the other hand, cash balance ¥6,946.2B and interest-bearing debt ¥1,777.63B with interest coverage around 8.9x support short- to medium-term dividend maintenance. Key monitoring points are Operating CF profitability and expansion after Q2 and progress in AR and inventory compression and FX stability.
[Short-term] Significant Operating CF improvement from working capital unwinding in Q2 (AR collection, inventory compression, trade payables restoration), sustained pricing effects in key markets (Japan, Russia, Turkey, US), further RRP share gains from new Ploom product launches (Ploom Aura new flavors in Japan, lyo device, etc.), and continued limited impact from Middle East developments.
[Long-term] Ploom global share expansion in RRP markets (Japan 15.8% → target low-20s; Italy 1.4% → target >5%), sustaining adjusted Operating Income constant-FX mid-to-high single-digit growth target, Processed Food margin improvement (4.6% → target double digits), avoidance of goodwill impairment realization and medium-to-long-term asset efficiency improvements, and strengthened ESG/regulatory response capacity reducing litigation risks.
Profitability & Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 33.0% | – | – |
| Net Income Margin | 21.3% | – | – |
Industry positioning: Although peer comparison data are limited, Operating Margin 33.0% and Net Income Margin 21.3% are estimated to rank among the upper tier of global tobacco majors (versus peers such as Philip Morris International, British American Tobacco), indicating strong price-setting power and high margins.
Growth & Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 15.2% | – | – |
Industry positioning: Revenue growth of 15.2% is high among peers for pricing-driven growth, with RRP market capture and FX contributions suggesting competitive advantage.
※ Source: Company aggregation
Extreme working capital volatility and liquidity risk: Very long working capital cycle (DSO 279 days, DIO 1,049 days, CCC 682 days) has led to low Operating CF / Net Income of 0.20x. Main drivers are timing distortions of prepaid/accrued tobacco taxes and receivable/inventory build from price adjustments. If unwinding does not progress in Q2 and beyond, liquidity pressure and prolonged dividend coverage shortfall are risks. The cash buffer of ¥6,946.2B and temporary short-term borrowing increases can provide short-term relief, but chronic issues would erode financial flexibility.
High goodwill and impairment risk: Goodwill ¥2,954.54B (71.8% of equity, 35.4% of total assets) reflects past M&A (Reynolds American, etc.) and could be impaired if future profitability or cash flow assumptions are not met. Under IFRS, annual impairment testing is required; increases in discount rates, market share loss, or regulatory tightening could trigger impairment. A large impairment would sharply reduce Equity Ratio and damage market confidence.
Regulatory and litigation risk realization: Tobacco tax hikes, stricter advertising/packaging/use regulations could reduce demand by lowering price elasticity. Litigation risks similar to the Canada settlement (Annual contribution booking) are ongoing. Escalation of Middle East tensions could cause direct operational constraints, FX volatility, and macro instability, potentially causing simultaneous declines in revenue, profit, and cash flow.
Sustainability of price-led profit growth and high-margin structure: Extremely high margins — Operating Margin 33.0%, Net Income Margin 21.3%, Adjusted Operating Margin 34.2% — reflect strong pricing power in the global tobacco market. Pricing effects +¥682B drove Q1 profit growth, and Adjusted Operating Income grew +20.5% on a constant-FX basis. RRP growth led by Ploom (+44.2% volume) alongside stable Combustibles share suggests coexisting drivers for medium-term growth. However, regulatory/litigation risks and high goodwill profile introduce volatility and require continuous monitoring for impairment risk or tax/regulatory headwinds.
Cash conversion vulnerability and working capital management challenge: Operating CF / Net Income 0.20x, CCC 682 days, and insufficient FCF coverage of dividends are near-term warning signs, mainly due to seasonality and tobacco-tax related cash distortions. Progress in Q2 and beyond on AR collection (DSO reduction), inventory compression (DIO reduction), and trade payables restoration (DPO extension) will be pivotal for investment decisions. If Operating CF approaches Net Income and FCF covers dividends by half/full-year, the coexistence of high dividend yield and financial stability can be confirmed; delays would increase liquidity and dividend sustainability concerns.
RRP market share expansion and visibility of future growth: Ploom shares in Japan 15.8% (+1.8pt) and Italy 1.4% (+0.7pt) indicate accelerating share gains in RRP markets. Volume growth of +44.2% directly contributes to top-line expansion and future profit potential. However, competition (IQOS, etc.) and possible deceleration of overall category growth present risks to sustained share momentum and profitability. Achieving adjusted Operating Income constant-FX mid-to-high single-digit growth depends critically on accelerating monetization of the RRP business; post-Q1 market share and margin trends will be key indicators.
This report is an earnings analysis document automatically generated by AI integrating XBRL financial statement data and PDF earnings presentation materials. It does not constitute a recommendation to invest in any specific security. Industry benchmarks are reference information compiled by the company from publicly disclosed financials. Investment decisions are your responsibility; please consult a professional advisor as needed.